Peptide powder purity, assay and active content: how to read a supplier COA

What does 98% HPLC purity actually describe?

An HPLC area percentage describes the share of integrated detector response assigned to a peak under a particular method. Water, some carriers and components that the detector does not measure adequately may contribute little or no comparable signal. The resulting percentage therefore cannot automatically be treated as a weight fraction of peptide in the container. Ask the supplier whether the number is chromatographic purity, a calibrated assay or an informal product description. Those are different statements. A useful COA gives the method identifier, acceptance limit and actual batch result together.

ICH Q2(R2) treats identity, assay and impurity measurements as different analytical purposes. Its formal scope concerns pharmaceutical analytical procedures. Cosmetic buyers can borrow that distinction when asking what a test establishes, without presenting the guideline as a cosmetic certification. [1]

Questions for the analytical report

• Which peak is assigned to the peptide, and what supports that assignment?
• What detector and integration rules produced the percentage?
• Is the result a peak-area ratio or a calibrated amount?
• Does the method account for the supplied matrix and relevant related substances?

Connect the peptide name to the complete supplied material

A purchasing line that contains only an ingredient name leaves several decisions unresolved. The supplied material may be a peptide salt, a defined copper complex, a blend with a carrier, or a solution that is later freeze-dried. Obtain the composition statement and confirm which component the assay measures. Record whether the value applies to the material as supplied, after a stated water correction, or on another defined basis. Counterions and declared excipients can affect the relationship between total powder mass and peptide-equivalent content.

FDA's ingredient supplier fact sheet explains that ingredient names and trade names have different labeling roles. [2] Keep the commercial item code, declared ingredient identity, specification revision and batch number connected in the purchasing record. A similar product title from another seller does not establish equivalence.

Keep these fields separate

Calculate active content on one consistent basis

Use a mass balance only after the assay basis is clear. In a hypothetical example, a supplier declares a blend containing 10.0% peptide by mass as supplied. Adding 1.00% of that blend to a finished cosmetic gives a nominal peptide contribution of 0.100% by mass, equivalent to 1,000 ppm. This is arithmetic, not a recommended cosmetic use level, a safety limit or evidence of efficacy. It also assumes that the assay definition matches the peptide basis you intend to report.

Do not multiply an as-supplied assay by a water correction again. If a result is reported on a dry basis, ask the analytical team how it converts to the delivered material. Record every conversion in the formula worksheet so procurement and formulation staff use the same denominator.

Worked example, not a product specification

• Supplied-blend assay: 10.0% by mass as supplied.
• Illustrative blend addition: 1.00% by mass of the finished formula.
• Nominal peptide contribution: 10.0% × 1.00% ÷ 100 = 0.100%.
• Unit conversion: 0.100% = 1,000 ppm by mass.
• The qualified formulator must select the actual use level and confirm finished-product suitability.

Resolve contradictory documents before accepting a batch

A specification stating an assay range and a COA listing only HPLC purity leave an unanswered release question. Send a written request that identifies the missing result, the applicable method and the batch concerned. If the supplier changes the reporting basis between the quotation, sample and commercial shipment, reconcile those records before comparing costs or releasing stock. Keep the agreed response with the receiving inspection record. An email explanation can help interpret a document, but acceptance should use the controlled specification and batch evidence.

For repeat orders, compare method revisions as well as results. A changed method can produce a changed number without an equivalent change in the material. Your quality team should decide whether additional comparison work is necessary for the intended cosmetic application.

A concise discrepancy request

• Identify the item code and batch.
• Quote the specification attribute that remains unreported.
• Request the actual result, unit and method revision.
• Ask how the result relates to the composition statement.
• Record who approved the resolution and which documents now control acceptance.